Cangene Corporation · Winnipeg, MB Canada (Toronto: CNJ)
| 155 Innovation Dr. | Phone: +1-204-275-4200 |
| Winnipeg, MB | Fax: +1-204-269-7003 |
| R3T 5Y3 | |
| Canada | 
Map This Company |
Cangene Corporation Rankings
Company Description
Cangene is excited about hyperimmunes. The company makes plasma products known as hyperimmunes, which are protein-based therapeutics used to treat immune system conditions, including infectious diseases and genetic disorders. Its top selling product WinRho, treats immune thrombocytopenic purpura, a blood clotting disorder, and hemolytic disease of the newborn, which occurs when a fetus' blood type is incompatible with its mother's. Cangene has several approved products and is developing others, mainly in the areas of infectious disease and biodefense. Generic giant
Cangene Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Toronto: CNJ Headquarters |
|---|---|
| Fiscal Year-End | July |
| 2011 Employees | 771 |
Executives
21 executives listed for Cangene Corporation's Winnipeg, MB location.
| Director | Bruce Burlington | |
|---|---|---|
| Director | Scott Lillibridge | |
| Director | Philip Johnson |